COLON TUMOR, MALIGNANT

Clinical trials for COLON TUMOR, MALIGNANT explained in plain language.

Never miss a new study

Get alerted when new COLON TUMOR, MALIGNANT trials appear

Sign up with your email to follow new studies for COLON TUMOR, MALIGNANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Targeted drug tested for tough cancers with rare genetic flaw

Disease control Terminated

This study tested whether the drug niraparib could help control advanced solid tumors in patients whose cancer has a specific genetic change called a PALB2 mutation. It involved 22 adults with various cancers (like breast, lung, or pancreatic) that had spread or were locally adva…

Matched conditions: COLON TUMOR, MALIGNANT

Phase: PHASE2 • Sponsor: Tempus AI • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

COLON TUMOR, MALIGNANT

Get alerted when new COLON TUMOR, MALIGNANT trials appear

Targeted drug tested for tough cancers with rare genetic flaw